| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 53.82B | 45.80B | 52.95B | 43.63B | 42.40B | 37.19B |
| Gross Profit | 5.06B | 5.20B | 4.82B | 3.79B | 4.02B | 3.99B |
| EBITDA | 2.76B | 2.96B | 2.49B | 1.78B | 1.97B | 2.06B |
| Net Income | 1.90B | 2.09B | 1.71B | 1.10B | 1.90B | 1.31B |
Balance Sheet | ||||||
| Total Assets | 34.44B | 35.08B | 43.30B | 30.34B | 35.14B | 32.73B |
| Cash, Cash Equivalents and Short-Term Investments | 4.25B | 6.69B | 3.93B | 6.27B | 7.83B | 5.42B |
| Total Debt | 1.66B | 770.00M | 5.98B | 1.93B | 4.42B | 4.46B |
| Total Liabilities | 16.90B | 15.37B | 26.01B | 14.56B | 20.68B | 20.06B |
| Stockholders Equity | 17.54B | 19.70B | 17.29B | 15.77B | 14.45B | 12.67B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.43B | -6.29B | 1.51B | 1.80B | 1.57B |
| Operating Cash Flow | 0.00 | 8.45B | -6.13B | 1.52B | 1.82B | 1.60B |
| Investing Cash Flow | 0.00 | -305.00M | -137.00M | -507.00M | 711.00M | -33.00M |
| Financing Cash Flow | 0.00 | -5.38B | 3.93B | -2.57B | -125.00M | -551.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥15.85B | 10.00 | ― | 3.71% | -20.23% | -34.79% | |
71 Outperform | ¥16.47B | 8.08 | ― | 2.87% | -1.65% | -12.79% | |
70 Outperform | ¥15.37B | 6.90 | ― | 1.39% | -4.03% | 82.21% | |
68 Neutral | ¥12.22B | 9.58 | ― | 1.01% | -13.50% | 22.11% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥10.38B | 9.54 | ― | 4.35% | -3.89% | 45.24% | |
59 Neutral | ¥12.71B | 11.13 | ― | 5.36% | 2.95% | 65.93% |